Recombinant Human Vascular Endothelial Inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant Human Vascular Endothelial Inhibitor, covering 2023-09-21 to 2023-09-21. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer [Phase 2]